Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Prognostic Value DCE-MRI Parameters In Predicting Factor Disease Free Survival And Overall Survival For Breast Cancer Patients.

N. Tuncbilek, F. Tokatli, S. Altaner, Atakan Sezer, M. Türe, I. Omurlu, O. Temizoz
Published 2012 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
PURPOSE The aim of the study is to assess the predictive power of DCE-MRI semi-quantitative parameters during treatment of breast cancer, for disease-free (DFS) and overall survival (OS). MATERIALS AND METHODS Forty-nine women (age range, 28-84 years; mean, 50.6 years) with breast cancer underwent dynamic contrast enhancement MRI at 1.0T imaging, using 2D FLASH sequences. Time intensity curves (TICs) were obtained from the regions showing maximal enhancement in subtraction images. Semi-quantitative parameters (TICs; maximal relative enhancement within the first minute, E (max/1); maximal relative enhancement of the entire study, E(max); steepest slope of the contrast enhancement curve; and time to peak enhancement) derived from the DCE-MRI data. These parameters were then compared with presence of recurrence or metastasis, DFS and OS by using Cox regression (proportional hazards model) analysis, linear discriminant analysis. RESULTS The results from of the 49 patients enrolled into the survival analysis demonstrated that traditional prognostic parameters (tumor size and nodal metastasis) and semi-quantitative parameters (E(max/1), and steepest slope) demonstrated significant differences in survival intervals (p<0.05). Further Cox regression (proportional hazards model) survival analysis revealed that semi-quantitative parameters contributed the greatest prediction of both DFS, OS in the resulting models (for E(max/1): p=0.013, hazard ratio 1.022; for stepest slope: p=0.004, hazard ratio 1.584). CONCLUSION This study shows that DCE-MRI has utility predicting survival analysis with breast cancer patients.
This paper references
10.1148/RADIOLOGY.220.1.R01JL3113
MR imaging of the breast for the detection, diagnosis, and staging of breast cancer.
S. Orel (2001)
10.1148/RADIOLOGY.193.1.8090898
Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
B. Kim (1994)
10.1259/BJR.70.833.9227224
Dynamic MR imaging of invasive breast cancer: correlation with tumour grade and other histological factors.
S. Mussurakis (1997)
10.1034/J.1600-0455.2003.00080.X
Can contrast-enhanced MR imaging predict survival in breast cancer?
B. Bóné (2003)
10.1016/J.EJRAD.2003.11.004
Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers.
N. Tuncbilek (2005)
Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.
J. Folkman (1995)
10.1148/RADIOLOGY.200.3.8756909
Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
L. Buadu (1996)
Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.
H. Hawighorst (1997)
10.1634/THEONCOLOGIST.8-6-521
Update on locally advanced breast cancer.
S. Giordano (2003)
10.1186/1471-2407-10-398
Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival
C. Mcardle (2010)
10.1002/BJS.1800730407
Adjuvant radiotherapy and chemotherapy in breast cancer
C. Mcardle (1986)
Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.
H. Hawighorst (1998)
10.1080/02841859809172195
Contrast-enhanced MR imaging as a prognostic indicator of breast cancer
B. Bóné (1998)
10.1093/annonc/mdn043
Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?
S. Bahri (2008)
10.1097/RLI.0b013e3181a64ce9
Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical Cancer
W. Yuh (2009)
10.1259/BJR/14883856
High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement.
H. Neubauer (2003)
10.2214/AJR.183.6.01831805
Contrast-enhanced high-resolution MRI of invasive breast cancer: correlation with histopathologic subtypes.
K. Kitagawa (2004)
10.1002/1097-0142(20010615)91:12<2230::AID-CNCR1253>3.0.CO;2-T
Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma
W. Reddick (2001)
10.1002/1097-0142(19911115)68:10<2142::AID-CNCR2820681010>3.0.CO;2-D
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index
D. Henson (1991)
10.1148/RADIOLOGY.218.2.R01FE37562
MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.
K. Turetschek (2001)
10.1056/NEJM199512283332608
Clinical Applications of Research on Angiogenesis
J. Folkman (1995)
10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
C. Carter (1989)
10.1016/j.otohns.2010.02.011
Cases
R. Rosenfeld (2010)
10.1016/j.ejrad.2008.05.007
Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy.
M. Pickles (2009)
10.1056/NEJM199101033240101
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.
N. Weidner (1991)
10.1007/BF02967594
Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer
T. Nagashima (2002)
Correlation between numeric gadolinium-enhanced dynamic MRI ratios and prognostic factors and histologic type of breast carcinoma
成定 宏之 (2006)
10.1016/S0360-3016(98)00365-4
Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
E. Touboul (1999)
10.1016/S0002-9610(05)80692-0
New horizons in the diagnosis and treatment of breast cancer using magnetic resonance imaging.
M. Cross (1993)
10.1007/s00330-003-2000-y
Invasive breast cancer: correlation of dynamic MR features with prognostic factors
B. Szabó (2003)
Dynamic breast MR imaging: are signal time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101–10
CK Kuhl (1999)
10.1182/blood-2008-08-173104
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival.
T. T. Shih (2009)
10.1080/02841860600702068
Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among ‘high risk’ pre- and postmenopausal breast cancer patients
L. Rutqvist (2006)
10.1148/RADIOLOGY.211.1.R99AP38101
Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?
C. Kuhl (1999)
10.1097/00004424-199412000-00006
Correlation Between Contrast Enhancement in Dynamic Magnetic Resonance Imaging of the Breast and Tumor Angiogenesis
C. Frouge (1994)



This paper is referenced by
10.1186/s13048-017-0362-z
The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas
Su Juan Yuan (2017)
10.1016/j.cmpb.2017.12.015
Spatiotemporal features of DCE-MRI for breast cancer diagnosis
Masood Banaie (2018)
10.1007/s00330-012-2740-7
Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage
Bingsheng Huang (2012)
10.1016/J.BREASTDIS.2013.01.023
Prognostic value DCE-MRI parameters in predicting factor disease free survival and overall survival for breast cancer patients
M. Su (2013)
10.1016/j.ejrad.2015.07.012
Recurrence-free survival in breast cancer is associated with MRI tumor enhancement dynamics quantified using computer algorithms.
M. Mazurowski (2015)
10.1002/jmri.26221
Intravoxel incoherent motion diffusion‐weighted MRI of invasive breast cancer: Correlation with prognostic factors and kinetic features acquired with computer‐aided diagnosis
S. Song (2019)
DCE-MRI in assessment of tumor hypoxia, radiation response, and metastatic potential
Kirsti Marie Øvrebø (2013)
10.1007/978-3-319-39147-2_17
MR-Derived Biomarkers for Cancer Characterization
Eugene Kim (2017)
10.1067/j.cpradiol.2018.03.003
Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast Cancer.
B. Dogan (2019)
10.1016/j.compmedimag.2013.04.003
Statistical Learning Algorithm for in situ and invasive breast carcinoma segmentation
J. Jayender (2013)
10.1177/0284185119885116
Feasibility of contrast-enhanced MRI derived textural features to predict overall survival in locally advanced breast cancer
Ioanna Chronaiou (2019)
10.1007/s00330-014-3502-5
Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators
M. Pickles (2014)
Nonmodel-based Dynamic Contrast-enhanced Magnetic Resonance Imaging for the Assessment of High versus Low Risk Carotid Atherosclerosis
David B. Maclean (2011)
10.1016/j.ejrad.2019.06.022
Abbreviated breast MRI combining FAST protocol and high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence.
Audrey Milon (2019)
10.1148/radiol.2017162079
Computer-aided Diagnosis-generated Kinetic Features of Breast Cancer at Preoperative MR Imaging: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer.
J. Kim (2017)
10.1136/amiajnl-2012-001460
Research and applications: Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer
D. I. Golden (2013)
10.2174/1573405613666170912115617
A Brief Review on Breast Carcinoma and Deliberation on Current Non Invasive Imaging Techniques for Detection.
R. Vairavan (2019)
10.1097/RLI.0000000000000222
Pretreatment Prognostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Vascular, Texture, Shape, and Size Parameters Compared With Traditional Survival Indicators Obtained From Locally Advanced Breast Cancer Patients
M. Pickles (2016)
10.1259/bjr.20190712
Kinetic volume analysis on dynamic Contrast-enhanced MRI of Triple-Negative breast cancer: Associations with survival outcomes.
Yoko Hayashi (2019)
10.1002/jmri.24921
Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis
B. Chaudhury (2015)
10.1102/1470-7330.2013.9003
Incorporating prognostic imaging biomarkers into clinical practice
W. P. Law (2013)
10.1371/journal.pone.0195756
Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer
S. Y. Nam (2018)
10.1118/1.4898202
Models and methods for analyzing DCE-MRI: a review.
F. Khalifa (2014)
Semantic Scholar Logo Some data provided by SemanticScholar